Oral mucositis secondary to head and neck chemoradiation displays a complex molecular
pathogenesis involving epithelial and microvascular injury, release of pro-inflammatory …

Oral mucositis (OM) remains a significant unmet need for patients being treated with
standard concomitant chemoradiation (CRT) regimens for head and neck cancers (HNC) …

Oral mucositis is a common side-effect associated with conventional cancer therapy and has
also recently been reported in association with newly emerging cancer therapies. It is …

Inflammation response of epithelial mucosa to chemo-radiotherapy cytotoxic effects leads to
mucositis, a painful side effect of antineoplastic treatments. About 40% of the patients treated …

Introduction The introduction of targeted therapy and immunotherapy has tremendously
changed the clinical outcomes and prognosis of cancer patients. Despite innovative …

The term mucositis is coined to describe the adverse effects of radiation and chemotherapy
treatments. Mucositis is one of the most common adverse reactions encountered in radiation …

Abstract Treatment of locally advanced head and neck carcinoma not amenable for surgical
resection or resected with high-risk features is usually based on (chemo-) radiation …

Oral mucositis (OM), a common debilitating toxicity associated with chemo-and radiation
therapies, is a significant unmet clinical need for head and neck cancer patients. The …

Oral mucositis is a common toxicity of high-dose chemotherapy and upper mantle head and
neck radiation. Published evidence from the past 14 months provides insight into the …

Opinion statement Oral mucositis (OM) causes significant detriment to patient quality of life.
Despite advances in RT, chemotherapy, and surgery for HNC which have led to improved …